Malignant Peripheral Nerve Sheath Tumor Rare Neurological Isolated Neoplasm Idrissi International Neurological Disorders

Primary malignant schwannoma is a rare neoplasm of nerve sheath origin. It is a cancer of the connective tissue surrounding nerves. Given its origin and behavior it is classiﬁ ed as sarcoma. The estimated incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) in general population is 0.001% and in patients with Neuroﬁ bromatosis 1 (NF-1) is 2-5%. It is an uncommon spindle cell sarcoma accounting for approximately 5% of all soft-tissue sarcoma. They are highly aggressive and occur in the second or third decade. This neoplasm usually affects the extremities. There is strong association between MPNSTs and neuroﬁ bromatosis (NF-1) and previous irradiation. We present the case of a 61-year-old woman manifesting with recurrent sciatalgy near for the fourth and ﬁ fth lumbar vertebral bodies. She underwent resection of a mass at the L4-5 level that was subsequently recognized as a malignant peripheral nerve sheath tumor.


INTRODUCTION
Malignant Peripheral Nerve Sheath Tumor (MPNST) is extremely rare entity. However, it is of diagnostic importance because it is one of the most aggressive soft -tissue sarcomas. It is also called as neurofi brosarcoma as it arises from the neuroectodermal lining of the peripheral nerves. MPNSTs are oft en associated with NF1 in 30-50% and with previous irradiation in 4-11% while 0.001% arise de novo in the general population [1,2]. Th ey oft en aff ect the head, trunk, and extremities; they lead to poor overall survival [3].

CASE REPORT
A 61-year-old female patient presented with history of persistent pain in the lowest segment of the lumbar region and sciatalgy since two years, without favourable evolution using medical treatment. Physical examination revealed a sensibility on her lumbar vertebrae near for the L4-L5. Nerve function and the remainder of general examination were normal without skin, skeletal or ocular anomalies. Computed Tomography (CT) scan showed a medullar necrotic rounded mass lesion at the L4-L5 level. Histopathological examination of the specimen revealed a tumor composed of spindle shaped cells with elongated hyperchromatic nuclei, arranged in long and short fascicles. Cells were arranged around hyaline bands in the form of cords and at places they were arranged in whorls ( Figure 1). Some of the tumor cells had marked nuclear pleomorphism. Th e stroma showed extensive areas of necrosis and hemorrhage. Th e blood vessels showed hyalinized walls. Mitotic fi gures were more than fi ve per high-power fi eld ( Figure 2). Immunohistochemically, the tumor cells showed diff use and strong positivity for S-100 ( Figure  3). However, they were negative for Pan-cytokeratin (AE1/ AE3), Desmin, and Human Melanoma Black (HMB) 45. Based on this data, a diagnosis of MPNST was made.

DISCUSSION
MPNSTs are malignant tumors developing from cells of peripheral nerve tissue [2]. Th ey are also called neurofi brosarcomas, malignant schwannoma or neurogenic sarcoma and account for approximately 5-10% of all soft -tissue sarcomas and about one-fourth to one-half occur in the setting of NF-1 [4]. Th e MPNST is typically a disease of adult life, as most tumors occur in patients of 20-50 years of age [5]. It does not exhibit any sex diff erences [4]. Th e age of onset tends to be lower in cases associated with NF-1 [6].

ABSTRACT
Primary malignant schwannoma is a rare neoplasm of nerve sheath origin. It is a cancer of the connective tissue surrounding nerves. Given its origin and behavior it is classifi ed as sarcoma. The estimated incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) in general population is 0.001% and in patients with Neurofi bromatosis 1 (NF-1) is 2-5%. It is an uncommon spindle cell sarcoma accounting for approximately 5% of all soft-tissue sarcoma. They are highly aggressive and occur in the second or third decade. This neoplasm usually affects the extremities. There is strong association between MPNSTs and neurofi bromatosis (NF-1) and previous irradiation. We present the case of a 61-year-old woman manifesting with recurrent sciatalgy near for the fourth and fi fth lumbar vertebral bodies. She underwent resection of a mass at the L4-5 level that was subsequently recognized as a malignant peripheral nerve sheath tumor.

ISSN: 2639-7021
More than 50% patients with MPNSTs suff er from NF-1, our case is not integrated in the syndrome of NF-1 it presents a form of an isolated neoplasm.
Th e most common anatomical sites for MPNST include extremities, head and neck region and trunk. Evans et al showed in their study about 32 cases of MPNST with Twelve (38%) occurred in deep locations with no superfi cial signs of a plexiform tumor. Many others occurred on major nerve routes such as the brachial plexus or sciatic nerve. Few tumors occurred at extremities [7].
CT fi ndings of MPNSTs usually include a large heterogeneous mass with occasional bony destruction. At MRI, Th e signal intensity of the tumors on T1WI is equal to or slightly greater than that of muscles. T2WI reveals high signal intensity and heterogeneous enhancement with partial central necrosis aft er contrast enhancement [8]. Th e most accurate radiographic evaluation of MPNST uses a combination of PET along with CT or MRI [9]. However diagnosis could not be made only on the basis of imaging studies, but it needs histological confi rmation.
Histopathologically, MPNSTs are characterized by atypical spindle-shaped cells with nuclear pleomorphism, frequent mitosis, and a high proliferative index. Tumor cells show S-100 immunopositivity, implying nervous origin, and vimentin immunopositivity, implying a mesenchymal origin-sarcoma [10]. Th e pathologic diagnoses of peripheral nerve sheath tumors with atypia represent a histologic continuum, and include neurofi broma with atypical features, lowgrade MPNST, and high-grade MPNST [9].
MPNSTs have to be diff erentiated on the one hand from neurofi bromas sand schwannomas and on the other form the others spindle cell sarcomas. Schwannomas are encapsulated tumors of nerve sheath with palissading form of nuclei, without mitotic activity or nuclear atypia. MPNSTs are hyper-cellular and show pleomorphism and mtotic fi gures. Low grade MPNSTs arising from neurofi broma is diagnosed when there is generalized nuclear atypia, increased cellularity and unusually low-levels of mitotic activity [2].
Malignant transformation is extremely rare in schwannomas, with fewer than 20 reported cases. Unlike neurofi bromas, which most oft en give rise to conventional spindle cell malignant peripheral nerve sheath tumors. Sarcomas arising in schwannomas frequently show epithelioid morphology, including epithelioid malignant peripheral nerve sheath tumor and epithelioid angiosarcoma [11]. Th e most common metastatic site of MPNST is the lung. According to Wise et al. [12] the prognosis of MPNSTs is poor and have 5 year survival rate of 20-50%. Large tumor size ( > 5 cm), presence of neurofi bromatosis, and total resection are most important prognostic indicators [13]. Histologic fi ndings such as cellularity, pleomorphism, mitotic activity, and size also contribute in assessing the prognosis [14]. Wong et al. [14,15] reported that adjuvant irradiation ( > 60 Gy) and inclusion of intraoperative electron irradiation were associated with better local disease control. Our patient received routine adjuvant chemotherapy aft er complete resection without complications or recurrence.

CONCLUSION
Our case point out that in case of persistent pain and resistant to medical therapy, associated with alterations of sensitivity, neoplastic causes including the tumors of the nervous system should be considered. Although malignant medullary tumors are rare, MPNSTs should be included in the diff erential diagnosis of the nervous system tumors. Complete resection and administration of routine adjuvant chemotherapy are the treatment of choice.